Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
These side effects are usually mild and temporary, but its important to communicate any concerns with your healthcare provider
Shipping Methods Standard shipping options are available at checkout Shipping costs are calculated at checkout based on destination and order size Delivery Timeframes Estimated delivery times vary based on location and carrier
The health quiz is free
Cost and Rules Insurance providers follow strict guidelines on what they cover
Redefining metabolic care with breakthrough innovation At Swasthya Healthcare, we are driving a new era in diabetes and weight managementwhere science meets precision to deliver real patient impact Our Tirzepatide Injection represents next-generation dual incretin therapy, empowering clinicians to tackle complex metabolic challenges with greater confidence and effectiveness Key highlights: Advanced dual GIP & GLP-1 receptor activation Powerful glycemic control with reduced glucagon response Clinically aligned support for weight management Improves metabolic outcomes with a holistic approach Developed under stringent global quality standards Committed to transforming metabolic health through innovation, accessibility, and excellencebringing better outcomes within reach
Two common GLP-1 agonists are: Semaglutide Sold under the brand names Wegovy and Ozempic , semaglutide is FDA-approved for weight loss and diabetes management
US$ 23.09
US$ 28.58
US$ 29.68
US$ 25.56
US$ 28.28
